A brief overview of amyloids and Alzheimer's disease

被引:129
作者
Ow, Sian-Yang [1 ]
Dunstan, Dave E. [1 ]
机构
[1] Univ Melbourne, Dept Chem & Biomol Engn, Melbourne, Vic 3010, Australia
关键词
amyloid fibrils; Alzheimer's disease; fibril structure; review; PAIRED HELICAL FILAMENTS; ATOMIC-FORCE MICROSCOPY; IN-VITRO FORMATION; BETA-PEPTIDE; FIBRIL FORMATION; PROTEIN AGGREGATION; GAMMA-SECRETASE; ALPHA-SECRETASE; KINETIC-MODEL; HEN LYSOZYME;
D O I
10.1002/pro.2524
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Amyloid fibrils are self-assembled fibrous protein aggregates that are associated with a number of presently incurable diseases such as Alzheimer's and Parkinson's disease. Millions of people worldwide suffer from amyloid diseases. This review summarizes the unique cross-beta structure of amyloid fibrils, morphological variations, the kinetics of amyloid fibril formation, and the cytotoxic effects of these fibrils and oligomers. Alzheimer's disease is also explored as an example of an amyloid disease to show the various approaches to treat these amyloid diseases. Finally, this review investigates the nanotechnological and biological applications of amyloid fibrils; as well as a summary of the typical biological pathways involved in the disposal of amyloid fibrils and their precursors.
引用
收藏
页码:1315 / 1331
页数:17
相关论文
共 50 条
[21]   Epigenetics in Alzheimer's Disease: A Critical Overview [J].
Villa, Chiara ;
Combi, Romina .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (11)
[22]   An animal model for Alzheimer's disease using racemic β-amyloids and excitatory amino acids [J].
Kaneko, I ;
Kubo, T ;
Morimoto, K ;
Kumagae, Y ;
Miller, CA .
FRONTIERS OF THE MECHANISMS OF MEMORY AND DEMENTIA, 2000, (1200) :97-100
[23]   MicroRNAs in the pathophysiology of Alzheimer's disease and Parkinson's disease: an overview [J].
Khezri, Mohammad Rafi ;
Yousefi, Keyvan ;
Zolbanin, Naime Majidi ;
Ghasemnejad-Berenji, Morteza .
MOLECULAR NEUROBIOLOGY, 2022, 59 (03) :1589-1603
[24]   MicroRNAs in the pathophysiology of Alzheimer’s disease and Parkinson's disease: an overview [J].
Mohammad Rafi Khezri ;
Keyvan Yousefi ;
Naime Majidi Zolbanin ;
Morteza Ghasemnejad-Berenji .
Molecular Neurobiology, 2022, 59 :1589-1603
[25]   Formation and participation of nano-amyloids in pathogenesis of Alzheimer's disease and other amyloidogenic diseases [J].
Maltsev A.V. ;
Galzitskaya O.V. .
Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry, 2010, 4 (3) :228-236
[26]   Pharmacotherapy of Alzheimer's disease: an overview of systematic reviews [J].
Majidazar, Reza ;
Rezazadeh-Gavgani, Erfan ;
Sadigh-Eteghad, Saeed ;
Naseri, Amirreza .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (10) :1567-1587
[27]   Ethical issues in Alzheimer's. disease: an overview [J].
Leuzy, Antoine ;
Gauthier, Serge .
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2012, 12 (05) :557-567
[28]   An overview on the impact of viral pathogens on Alzheimer's disease [J].
Amelimojarad, Melika ;
Amelimojarad, Mandana ;
Cui, Xiaonan .
AGEING RESEARCH REVIEWS, 2025, 104
[30]   Lipid Integration in Neurodegeneration: An Overview of Alzheimer's Disease [J].
Yadav, Rajesh Singh ;
Tiwari, Neeraj Kumar .
MOLECULAR NEUROBIOLOGY, 2014, 50 (01) :168-176